# Non-alcoholic Fatty Liver studies recruiting: 80 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 80 trials that are observational for Non-alcoholic Fatty Liver Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Non-alcoholic Fatty Liver Disease studies: 80 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/non-alcoholic-fatty-liver-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 80
- Recruiting or not yet: 80
- Read on: November 19, 2026

## Trials

The 25 newest of 80, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 21, 2026 | NCT07884903 | Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks | Shanxi Bethune Hospital | Observational | Not yet recruiting | Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)... | 25,974 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884903) |
| October 6, 2026 | NCT07861594 | Lifestyle, Dietary Patterns, and Cardiometabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Among People Living With... | Assiut University | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), HIV Infections, Non-Alcoholic Fatty Liver Disease... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861594) |
| September 22, 2026 | NCT07834905 | Nutritional Indices and Inflammatory Markers in MASLD | Assiut University | Observational | Not yet recruiting | Liver Fibrosis, Malnutrition, Non-Alcoholic Fatty Liver Disease | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834905) |
| September 18, 2026 | NCT07827430 | Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD | Assiut University | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease, Hypothyroidism, Liver... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827430) |
| August 28, 2026 | NCT07793279 | Hypothyroidism and Liver Fibrosis Severity in MASLD | Assiut University | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Hypothyroidism, Liver Cirrhosis, Non-Alcoholic Fatty Liver... | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793279) |
| August 20, 2026 | NCT07775638 | Detecting Liver Fibrosis in Patients At-risk | Helse Stavanger HF | Observational | Not yet recruiting | Fatty Liver, NAFLD - Non-Alcoholic Fatty Liver Disease, Nash, MASLD (Metabolic Dysfunction-Associated Steatotic Liver... | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775638) |
| July 28, 2026 | NCT07731360 | Non-Invasive Diagnostic Panel for MASLD in Children With Obesity | Kayseri City Hospital | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity, Insulin Resistance Syndrome | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731360) |
| July 21, 2026 | NCT07716384 | Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness | Second Affiliated Hospital of Xi'an Jiaotong University | Observational | Not yet recruiting | Liver Fibrosis, Liver Cirrhosis, NAFLD (Nonalcoholic Fatty Liver Disease), HEPATITIS B CHRONIC | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716384) |
| June 23, 2026 | NCT07662356 | Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity | Chinese University of Hong Kong | Observational | Recruiting | Nonalcoholic Fatty Liver Disease (NAFLD) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662356) |
| June 22, 2026 | NCT07658755 | Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme | Hospital General Universitario Gregorio Marañon | Observational | Recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis, Non-alcoholic Fatty Liver Disease NAFLD, Type... | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07658755) |
| June 12, 2026 | NCT07644936 | Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | Observational | Not yet recruiting | Autoimmune Hepatitis, Non-Alcoholic Fatty Liver Disease | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07644936) |
| January 13, 2026 | NCT07336563 | ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH), Metabolic... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336563) |
| January 7, 2026 | NCT07321925 | Thermoacoustic Method for Estimating Liver Fat Fraction | Endra Lifesciences | Observational | Recruiting | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated... | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321925) |
| November 25, 2025 | NCT07248371 | Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases | Chang Gung Memorial Hospital | Observational | Recruiting | Metabolic Syndrome (MetS), Obesity & Overweight, Cardiovascular Diseases (CVD), Chronic Kidney Disease, Nonalcoholic... | 6,266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07248371) |
| November 21, 2025 | NCT07241195 | A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic... | The Affiliated Hospital of Hangzhou Normal University | Observational | Recruiting | NAFLD and NASH, NAFLD( Non-alcoholic Fatty Liver Disease ), NAFLD Cirrhosis | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07241195) |
| September 11, 2025 | NCT07168551 | Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients | Assiut University | Observational | Not yet recruiting | Hyperuricemia, NAFLD (Nonalcoholic Fatty Liver Disease), Liver Fibrosis | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07168551) |
| September 2, 2025 | NCT07149571 | To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in... | Tongji Hospital | Observational | Recruiting | Nonalcoholic Fatty Liver Disease, Metabolic-associated Fatty Liver Disease | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07149571) |
| July 25, 2025 | NCT07086989 | Cardiovascular Risk in Children With Chronic Conditions Study | Semmelweis University | Observational | Recruiting | Kidney Transplant, Familial Hypercholesterolaemia, Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM)... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07086989) |
| July 17, 2025 | NCT07070362 | Digital Early Warning System for Acute Lung Injury in Liver Surgery | Beijing Tsinghua Chang Gung Hospital | Observational | Recruiting | Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human, MASLD, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic... | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07070362) |
| July 4, 2025 | NCT07051863 | Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease | Fondazione Epatocentro Ticino | Observational | Recruiting | NAFLD, MASH, NASH/MASH | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07051863) |
| May 16, 2025 | NCT06975579 | The COherence of Scatter Identification and Exclusion Algorithm Study | Institute of Cancer Research, United Kingdom | Observational | Recruiting | Steatohepatitis, Nonalcoholic | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06975579) |
| April 3, 2025 | NCT06908122 | Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences | Assiut University | Observational | Not yet recruiting | Non-alcoholic Fatty Liver Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06908122) |
| March 17, 2025 | NCT06879236 | Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | NASH, NAFLD | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06879236) |
| February 11, 2025 | NCT06819917 | Identification of Liver Fibrosis Biomarkers | Roche Diagnostics GmbH | Observational | Recruiting | Non-alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | 575 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06819917) |
| February 7, 2025 | NCT06814600 | Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients | Centre Hospitalier Universitaire Saint Pierre | Observational | Recruiting | NAFLD, Inflammatory Bowel Diseases, Steatosis, Fibrosis, Liver | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06814600) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 10 |
| Humanity and Health Research Centre | 3 |
| Beijing Friendship Hospital | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Centre Hospitalier Universitaire Saint Pierre | 1 |
| Manchester University NHS Foundation Trust | 1 |
| Hospital General Universitario Gregorio Marañon | 1 |
| Semmelweis University | 1 |
| Great China Fatty Liver Consortium Limited | 1 |
| Groupe Éthique et Santé | 1 |
| Roche Diagnostics GmbH | 1 |
| University of Roma La Sapienza | 1 |
| Steno Diabetes Center Copenhagen | 1 |
| Chang Gung Memorial Hospital | 1 |
| King Saud University | 1 |
| Shanxi Bethune Hospital | 1 |
| German Diabetes Center | 1 |
| State University of New York at Buffalo | 1 |
| Second Affiliated Hospital of Xi'an Jiaotong University | 1 |
| All India Institute of Medical Sciences, Bhubaneswar | 1 |
| University of Copenhagen | 1 |
| Kayseri City Hospital | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Xiangya Hospital of Central South University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 16 |
| United States | 10 |
| Italy | 6 |
| United Kingdom | 5 |
| Denmark | 4 |
| Germany | 4 |
| Belgium | 3 |
| Spain | 3 |
| Switzerland | 3 |
| France | 3 |
| Netherlands | 3 |
| Taiwan | 2 |
| India | 2 |
| Hong Kong | 2 |
| Hungary | 1 |
| Argentina | 1 |
| Saudi Arabia | 1 |
| Turkey (Türkiye) | 1 |
| Finland | 1 |
| Greece | 1 |
| Portugal | 1 |
| Sweden | 1 |
| Kuwait | 1 |
| South Korea | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Bookkeeping firms in the United States](https://specstream.ai/data/businesses/bookkeeping-firms/united-states)
- [Structural engineering firms in the United States](https://specstream.ai/data/businesses/structural-engineering-firms/united-states)
- [Medical law firms in the United States](https://specstream.ai/data/businesses/medical-law-firms/united-states)
- [Elementary schools in the United States](https://specstream.ai/data/businesses/elementary-schools/united-states)
- [Asian restaurants in the United States](https://specstream.ai/data/businesses/asian-restaurants/united-states)
- [Ramen restaurants in the United States](https://specstream.ai/data/businesses/ramen-restaurants/united-states)
